| HOME >> BIOLOGY >> TECHNOLOGY |
Doctors Disagree Over Which Drugs Are More Effective, According to a New
Report from Decision Resources
WALTHAM, Mass., Oct. 1 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Forest Laboratories' Lexapro and generics- dominated fluoxetine lead first-line therapy in the treatment of major depression. According to the new report entitled Treatment Algorithms in Major Depression, selective serotonin reuptake inhibitors (SSRIs), which include Lexapro and Prozac, account for 63.6 percent of patients on first-line therapy. Surveyed physicians indicate the reasons for SSRIs being so heavily used are efficacy, cost and physician familiarity. Eighty percent of surveyed psychiatrists and seventy percent of surveyed primary-care physicians (PCPs) said the reason why they chose SSRIs over benzodiazepines is efficacy. The major reason 49 percent of surveyed psychiatrists chose SSRIs over serotonin/norepinephrine reuptake inhibitors (SNRIs) is cost, while 49 percent of PCPs say they chose SSRIs over SNRIs owing to familiarity with the former class.
The report also finds that psychiatrists and PCPs do not all agree on what the most effective drugs are for treatment of major depression; therefore there is significant variation in the choice of agents, with no clear dominant player. Forty four percent of surveyed PCPs say SSRIs are more effective than SNRIs, but 72 percent of psychiatrists believe the opposite. Sixty two percent of surveyed PCPs think Lexapro's efficacy against depression is a major reason to choose it, but only 24 percent of surveyed psychiatrists agree.
"We project a significant increase in the use of SNRIs in first-line
therapy in the next two years," said Michael Malecki, Ph.D., analyst at
Decision Resources. "Forty five percent of surveyed psychiatrists and forty
eight percent of surveyed PCPs say they will mor
'/>"/>
| SOURCE Decision Resources Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. DeForest biodiesel plant begins production
2. Biodiesel plant being built in DeForest to make alternative fuel
3. Use of X-rays to advance wood-decay knowledge leads to honor for Forest Products Lab biologist
4. Biodiversity threatened as forests become islands of green, UW professor says
5. BioRobot MDx standardize your automated protocols in clinical laboratories
6. Distance-Learning Remote Laboratories using LabVIEW
7. States are the best laboratories for healthcare reform
8. Scientific Protein Laboratories Acquired by New York firm
9. The Genesis of Gendicine: The Story Behind the First Gene Therapy
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. TomoTherapy opens technical training center
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |